SMTL ID : 8gmn.4 (3 other biounits)

Crystal structure of human C1s in complex with inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x ZWK: [4-(1-aminophthalazin-6-yl)piperazin-1-yl](2-methylphenyl)methanone(Non-covalent)

ZWK.1: 14 residues within 4Å: Chain A: H.158, P.203, F.209, D.309, S.310, C.311, K.312, S.337, W.338, G.339, Q.341, C.342, Y.345, G.346 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:H.158, A:F.209 Hydrogen bonds: A:D.309, A:S.310, A:Q.341 Water bridges: A:L.347 pi-Stacking: A:H.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ikeda, Z. et al., Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway. J.Med.Chem. (2023)

Release Date

2023-05-17

Peptides

Complement C1s subcomponent: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Complement C1s subcomponent

Related Entries With Identical Sequence